Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Smouldering multiple myeloma represents an asymptomatic stage in the progression to multiple myeloma.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The focus of the investment is a manufacturing facility dedicated to producing drug substances for AstraZeneca.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JUNE 19, 2025

By GlobalData Learn more about Strategic Intelligence The company then plans to expand into a Phase Ib proof-of-concept trial in patients with KCNT1-related epilepsy in early 2026. The US Food and Drug Administration (FDA) has awarded ABS-1230 both orphan drug and rare paediatric designations.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JULY 16, 2025

Anticipated next steps involve generating preclinical candidate data packages, which will include non-human primate studies expected in early 2026. How will RFK Jr’s American dream for vaccines play out? Following these outcomes, Acumen holds exclusive rights to develop up to two development candidates.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 18, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 7, 2025

KalVista will receive an upfront payment of $11m, with an additional $11m contingent upon achieving a regulatory milestone anticipated by early 2026. How will RFK Jr’s American dream for vaccines play out? In April 2025, KalVista Pharmaceuticals granted Kaken Pharmaceutical the commercialisation rights for sebetralstat in Japan.

FDA 122

FDA Packaging Communication Hospitals 122

Pharmaceutical Technology

JUNE 19, 2025

As well as advancing DT-101, the new capital injection will also support the progression of two gamma-aminobutyric acid type A (GABA A ) receptor modulators towards clinical trials in 2026. These compounds have the potential for addressing a spectrum of neuropsychiatric disorders that currently lack adequate treatment options.

Communication 52

Communication Hospitals Packaging Compounding 52

Pharmaceutical Technology

JULY 25, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 24, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Vaccines 52

Vaccines Packaging Communication Immunization 52

Pharmaceutical Technology

JUNE 18, 2025

The PRV programme for rare paediatric diseases, signed into law in 2012, expired in late 2024 after it failed to make it into a US Congress funding package. This effectively pushed the programme into its ‘sunsetting phase’. Give your business an edge with our leading industry insights.

FDA 59

FDA Packaging Communication Hospitals 59

Pharmaceutical Technology

JULY 1, 2025

Takeda anticipates commencing commercialisation efforts for Gammagard liquid ERC in the US by 2026, with plans to follow suit in the European Union (EU) by 2027. GlobalData Strategic Intelligence US Tariffs are shifting - will you react or anticipate? Don’t let policy changes catch you off guard.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 15, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 23, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Communication 52

Pharmaceutical Technology

JULY 15, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 14, 2025

A target action date of 28 April 2026 has been set under the Prescription Drug User Fee Act (PDUFA). How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster.

FDA 52

FDA Packaging Hospitals Research Laboratories 52

Pharmaceutical Technology

JUNE 18, 2025

The candidate plans to enter Phase I human trials in early 2026. Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JULY 9, 2025

The financial impact of this agreement on JCR’s consolidated results for the fiscal year ending 31 March 2026 has already been included in the current earnings forecast. We may still continue to send you service-related and other non-promotional communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 16, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 59

Packaging Communication Hospitals Pharmaceutical Companies 59

Pharmaceutical Technology

JULY 16, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Documentation 52

Documentation FDA Communication Packaging 52

Pharmaceutical Technology

JULY 14, 2025

A decision by the FDA is expected in H1 2026. Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.

Labelling 52

Labelling Vaccines FDA Packaging 52

Pharmaceutical Technology

JUNE 11, 2025

June 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company intends to introduce its inaugural product candidate into clinical trials by 2026. The company is progressing several programmes, intending to introduce its inaugural product candidate into clinical trials by 2026.

Communication 52

Communication Hospitals Packaging Insurance 52

Pharmaceutical Technology

JULY 22, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here.

FDA 52

FDA Labelling Communication Packaging 52

Pharmaceutical Technology

JULY 15, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 75

Packaging Communication Hospitals Vaccines 75

Pharmaceutical Technology

JULY 16, 2025

Find out more Office of Management and Budget Director Russell Vought told reporters that the White House is on board with the substitute amendment to the rescissions package. How will RFK Jr’s American dream for vaccines play out? Data Insights The gold standard of business intelligence.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 14, 2025

Member states of the organisation agreed earlier this year to pay 20% more in membership fees to stopgap the US funding shortfall, though WHO’s overall budget for 2026-2027 will be lower than that for 2024-2025. How will RFK Jr’s American dream for vaccines play out? Sign up for our daily news round-up!

Vaccines 52

Vaccines Packaging Hospitals Communication 52

Pharmaceutical Technology

JULY 14, 2025

While the CRL will delay the potential approval of UX111 to 2026, we are working with urgency to respond and resubmit.” We may still continue to send you service-related and other non-promotional communications. How will RFK Jr’s American dream for vaccines play out? Sign up for our daily news round-up!

Communication 52

Communication Packaging Hospitals FDA 52

Pharmaceutical Technology

JULY 18, 2025

However, the PRV program for rare pediatric diseases is at risk of expiry in September 2026, and is pending renewal. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

FDA 52

FDA Packaging Communication Hospitals 52

Pharmaceutical Technology

JULY 17, 2025

It is an advanced sterile fill-finish and packaging site supported by more than 200 employees. How will RFK Jr’s American dream for vaccines play out? Find out more The Ridgefield site will continue to produce a range of therapies for Sanofi while expanding its capacity to meet increasing demands from other pharmaceutical and biotech firms.

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 18, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

Packaging 52

Packaging Communication Hospitals Insurance 52

Pharmaceutical Technology

JULY 15, 2025

Danish dermatology leader LEO Pharma has bought the rights to Boehringer Ingelheim’s psoriasis drug Spevigo (spesolimab) for €90m ($105m), strengthening its portfolio ahead of a possible public listing in 2026. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Vaccines 52

Pharmaceutical Technology

JULY 25, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here.

Communication 52

Communication Packaging Hospitals Insurance 52

Pharmaceutical Technology

JUNE 13, 2025

By GlobalData Learn more about Strategic Intelligence Moderna said it plans to have mRESVIA available for both both younger adults and older adults in the US in time for the 2025-2026 respiratory virus season. This usually begins around November and peaks in the mid-Winter months. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines FDA Labelling Communication 52

Pharmaceutical Technology

JULY 18, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. How will RFK Jr’s American dream for vaccines play out?

FDA 52

FDA Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 14, 2025

How will RFK Jr’s American dream for vaccines play out? Sectors Sections Clinical Trials Drug Manufacturers Therapy Area Pricing and Market Access Latest EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma Formulate Faster. Regulatory challenges and geopolitical disturbances continue to impede the safe delivery of shipments.

Communication 52

Communication Customer Service Packaging Hospitals 52

Pharmaceutical Technology

JULY 10, 2025

Always looking ahead and never standing still, Indena’s plans for 2026 include additional production lines dedicated to highly potent molecules (OEB 5 and OEB 6), including reactors up to 100 litres housed in gloveboxes and high-capacity contained dryers. How will RFK Jr’s American dream for vaccines play out?

Communication 52

Communication Packaging Hospitals Vaccines 52

Pharmaceutical Technology

JULY 17, 2025

Sarepta Therapeutics is set to cut 500 jobs as part of its restructuring and pipeline prioritisation plan, which is expected to result in annual cash cost savings of $120m in 2026. With its pipeline reprioritisation, the company anticipates delivering $300m in annual non-personnel cost savings from 2026.

Labelling 52

Labelling Communication Packaging Hospitals 52

Pharmaceutical Technology

JULY 21, 2025

EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices? Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.

Packaging 64

Packaging Pharmaceutical Companies Pharmaceutical Companies Communication 64